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Abstract
Background: Microfluidics is an enabling technology with a number of advantages over traditional
tissue culture methods when precise control of cellular microenvironment is required. However,
there are a number of practical and technical limitations that impede wider implementation in
routine biomedical research. Specialized equipment and protocols required for fabrication and
setting up microfluidic experiments present hurdles for routine use by most biology laboratories.
Results: We have developed and validated a novel microfluidic device that can directly interface
with conventional tissue culture methods to generate and maintain controlled soluble
environments in a Petri dish. It incorporates separate sets of fluidic channels and vacuum networks
on a single device that allows reversible application of microfluidic gradients onto wet cell culture
surfaces. Stable, precise concentration gradients of soluble factors were generated using simple
microfluidic channels that were attached to a perfusion system. We successfully demonstrated real-
time optical live/dead cell imaging of neural stem cells exposed to a hydrogen peroxide gradient
and chemotaxis of metastatic breast cancer cells in a growth factor gradient.
Conclusion: This paper describes the design and application of a versatile microfluidic device that
can directly interface with conventional cell culture methods. This platform provides a simple yet
versatile tool for incorporating the advantages of a microfluidic approach to biological assays
without changing established tissue culture protocols.
Background
Gradients of chemokines and growth factors play an
important role in many developmental and physiological
processes such as axon guidance [1], immune response
[2], morphogenesis [3], and cancer metastasis [4,5]. Tradi-
tionally, Boyden chamber [6], under-agarose assay [7],
and micropipette-based assay [8] have been used to study
cellular behavior in soluble gradients. Unfortunately,
these conventional assays are not capable of generating
and maintaining stable gradients over long periods due to
inherent limitations of their macroscale approach [6,7].
In addition, they typically require relatively large amounts
of costly reagents and often do not allow real-time moni-
toring of cell behavior.
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Recent developments in microfluidic devices that apply
miniaturization technologies from the microelectronics
industry have resulted in microscale devices that hold the
promise of overcoming limitations imposed by conven-
tional macroscale methods. Microfluidic devices that can
generate stable soluble and surface gradients of complex
profiles have been developed in last few years [9-11].
These gradient-generating microfluidic devices allow min-
iaturized real-time cellular assays [12-14] for investigating
migration [15], proliferation, differentiation [16], and
apoptosis [17]. We have previously reported on "Christ-
mas-tree" network-based microfluidic devices for investi-
gating migration of neutrophils [18,19] and metastatic
cancer cells [20,21] as well as differentiation of human
neural progenitor cells (NPCs) [16]. Although these
devices can create stable concentration gradients, one
important limitation has been the need to culture cells
inside the microfludic devices before each experiment.
Setting up a microfluidic experiment required at least 2–3
hours of preparation time for each set resulting in
throughput of 2–3 experiments a day. Furthermore, it was
difficult to perform experiments with sensitive cells such
as NPCs and neurons that did not plate well in the
devices.
Recently, a network of vacuum channels was used to pro-
vide uniform bonding to any underlying flat surface [22].
This vacuum-sealed microfluidic device was used to inves-
tigate the kinetics of leukocyte adhesion under defined
shear flow in 6-well tissue culture plates. Here we devel-
oped a novel hybrid microfluidic-vacuum device that
incorporates a network of vacuum channels and a micro-
fluidic gradient generator. Unlike the previous vacuum-
sealed device [22], which generates differential shear
stress, our hybrid microfluidic-vacuum device generates
concentration gradients of soluble factors in a single chip.
This device has several advantages over previous microflu-
idic devices that required bonding of two separate pieces:
(i) it allows the reversible application of microfluidic gra-
dients onto wet cell culture surfaces, (ii) it demonstrates
high reproducibility and functionality, and (iii) it is a
highly adaptable method for incorporating the advan-
tages of microfluidics to biological assays without chang-
ing well established tissue culture protocols. This hybrid
device is a versatile experimental platform that is compat-
ible with various wet biology protocols and should find a
number of applications in biomedical research.
Results and discussion
Design of the hybrid microfluidic-vacuum platform for 
gradient generation
Figure 1A is a schematic of the microfluidic-vacuum
device. Instead of irreversible bonding to create enclosed
channels, we used a hybrid design that incorporated sep-
arate channels for vacuum and liquids. The vacuum chan-
nels were used for reversible bonding to a hard surface. An
important consideration was to place the fluidic channels
in the center of the device and surround it with a network
of interconnected vacuum channels around the periphery.
For these studies, we incorporated a simple microfluidic
gradient generator composed of three inlet reservoirs and
one outlet. For fluid flow, a syringe pump connected to
channel outlet was operated in withdrawal mode to min-
imize pressurizing the device, which disrupted the seal
between device and culture surface.
There were no significant design limitations for vacuum
channels; a wide range of dimensions (50~500 μm wide)
and designs (nested squares and circles) were successfully
used. The vacuum channels were placed anywhere
between 0.2–2 mm away from the fluidic channels. When
the channels were placed closer, chance for leakage
between vacuum channels and fluidic channels was
greater, and it often led to failed seals. Due to the soft elas-
tomeric property of poly(dimethylsiloxane) (PDMS), the
vacuum channels provided dependable bonding of the
A hybrid microfluidic-vacuum platform for interfacing with  Petri dish Figure 1
A hybrid microfluidic-vacuum platform for interfacing with 
Petri dish. (A) Schematic design of the microfluidic device 
that show separate vacuum and fluidic channels. Side reser-
voirs (purple) contain buffer while buffer with FITC-Dextran 
(green) filled the middle reservoir. Parallel laminar flows 
from the three reservoirs generate stable gradients by diffu-
sion. (B) Gradients of varying slope and profile generated in a 
single device. Two different gradient profiles generated at 0.5 
mm and 6 mm downstream of the junction were visualized 
by FITC-Dextran profile. Gradient profiles were generated 
using 1 μl/min withdrawal rate. Experimentally measured and 
calculated gradient profiles were normalized for comparison. 
Scale bars are 100 μm.BMC Biotechnology 2007, 7:60 http://www.biomedcentral.com/1472-6750/7/60
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hybrid device onto flat glass or plastic. Surface coatings
(e.g. poly-L-lysine, laminin, and collagen) had no obvious
effects on vacuum bonding or on subsequent gradient
generation. In addition, we measured the vacuum force
on a tip of tubing connected with a syringe to the house
vacuum line. The vacuum pressure required to maintain
the seal was 1–10 torr (this value may vary depending on
device design and other experimental variables). Use of
house vacuum was sufficient for the experiments to work
reproducibly.
By flowing different solutions from the three inlet reser-
voirs, continuous laminar streams can generate stable gra-
dients that are perpendicular to the flow. Multiple
gradient profiles were generated at different downstream
positions of the inlets (e.g. a few mm apart) on a single
device and controlled by adjusting flow rates (0.3–1 μl/
min). Cells exposed to these flow rates in a gradient cham-
ber were subjected to fluid shear stress in the range of 4.2
× 10-3-1.4 × 10-2 dyne/cm2. This value is significantly
lower (approx. 2–3 orders of magnitude) than physiolog-
ical shear stress on endothelial cells during normal blood
flow (~2 dyne/cm2) [23]. Figure 1B shows two different
gradient profiles at 0.5 mm and 6 mm downstream from
the junction of fluidic channels (1 μl/min withdrawal
rate) containing fluorescein isothiocyanate (FITC)-dex-
tran (10 μM, MW = 10 kDa) in the middle reservoir, while
the side reservoirs contained buffer only. The gradients
could be maintained for 6~24 hours depending on reser-
voir capacity (150~600 μl) and flow rate. Gradient pro-
files of FITC-dextran compared favorably to simulation
results (Fig. 1B).
An important advantage of the hybrid microfluidic device
is that cell-based experiments can be routinely performed
due to simpler setup and shorter setup time compared to
conventional microfluidic gradient devices. Moreover,
cell cultures can be prescreened for optimal health, den-
sity, and distribution. Setup time was typically < 5 min,
allowing for several time-lapse cell migration experiments
per day. Microfluidic experiments could be initiated
whenever cells were ready in Petri dish or multi-well cul-
ture plates (our studies were performed using 6-well
plates). Other advantages are: (i) the hybrid device allows
experiments with sensitive cells (e.g. mouse NPCs, neu-
rons) that are difficult to culture inside microfluidic
devices, and (ii) reversible bonding allows for straightfor-
ward immunocytochemistry or other endpoint analyses
after gradient applications. To remove the device after an
experiment, vacuum was turned off after adding about 2
ml of media (enough to completely immerse the device in
a 6-well plate). After a few minutes, the device detached
from the surface and floated to the surface. Attachment
and viability of cells were not adversely affected by this
release process.
Although this device brings many advantages to cell cul-
ture studies, a limitation is that the design is not compat-
ible with complex fluidic networks. Long, serpentine
channels have a higher chance of bonding failure. Bond-
ing failure can occur if the surface is uneven (i.e. trapped
large debris) or if there is a leak between the vacuum net-
work and fluidic channels. Bonding failure rate was rela-
tively low (< 5%) and could be further reduced by using
simple fluidic channels and providing a sufficient gap
(0.2–2 mm) between the vacuum network and fluidic
channels. Device integrity and gradient quality were mon-
itored by checking the fluorescence gradient profile in the
microchannel by adding a small amount of fluorescent
dye in one of the reservoirs.
Real-time live and dead assay of mouse NPCs in a 
microfluidic device
Compared to human NPCs [16], we found that mouse
NPCs were difficult to culture inside irreversibly-bonded
microfluidic devices. Initial plating efficiency of mouse
NPCs was poor, and they displayed lower proliferation
rates and higher cell death rates compared to Petri dish
controls (data not shown). We therefore cultured mouse
NPCs in 6-well plates, then selected healthy cultures for
vacuum device application.
To test the ability of this device to seal and generate gradi-
ents, we exposed mouse NPCs to hydrogen peroxide
(H2O2) gradients, a rapid inducer of cell death [24,25]. To
simultaneously investigate cellular responses to fixed and
graded hydrogen peroxide concentrations, the fluidic
channel network contained both control and gradient
regions and time-lapse images were taken in both regions.
The control region had three microchannels that com-
bined into a single channel where gradients were formed
(Figure 2A). Cell-impermeant propidium iodide (PI) at 2
μg/ml was preloaded to identify dead cells before gradient
application. After 2 hours of exposure to hydrogen perox-
ide (right inlet) with a flow rate of 0.3 μl/min, cells in the
two left channels were alive and PI-negative (Figure 2B),
while cells in the right channel became PI-positive (Figure
2C) [see Additional File 1, 2]. In the gradient region, an
increasing number of cells showed PI staining over time
and from right to left as hydrogen peroxide diffused from
the right inlet channel and across the main channel (Fig-
ure 2D, E) [see Additional File 3, 4]. Cell death corre-
sponded well to the concentration of hydrogen peroxide
in both control and gradient chambers (Figure 2F, G). We
divided the gradient region into two areas based on the
mean concentration (25 mM) of hydrogen peroxide based
on simulations. (Note: for most experiments, fluorescent
gradient profiles of FITC-dextran with molecular weight
similar to agonist can be used to monitor gradient pro-
files. This was not performed here, since the molecularBMC Biotechnology 2007, 7:60 http://www.biomedcentral.com/1472-6750/7/60
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weight of hydrogen peroxide is much smaller than fluo-
rescent dyes).
During experimental setup, some cells become trapped at
the edges of channels (Fig. 2B, C) and might interact with
live healthy cells in the channels. These cell-cell interac-
tions might lead to false positive results. However, the
hybrid vacuum devices should minimize such results.
First, due to continuous perfusion, paracrine signaling by
trapped dead cells should be transient and minimal, par-
ticularly in the orthogonal direction. Second, one can
avoid interpretive pitfalls by avoiding cells near the edges.
Third, edge effects can be minimized by making the chan-
nels larger (lower edge/area ratio). These results con-
firmed the ability of vacuum to seal and isolate the
microfluidic channels using live cells grown on a Petri
dish.
Cancer cell chemotaxis
One of the main applications for microfluidic gradients
are studies on cell migration and chemotaxis [12-14]. To
further compare the hybrid microfluidic-vacuum device
to conventional microfluidic chemotaxis chambers, we
performed chemotaxis assays with MDA-MB-231, a
human metastatic breast cancer cell line. For our experi-
ment, epidermal growth factor (EGF) was used as a chem-
oattractant, since it has been implicated as an important
factor in breast cancer cell metastasis, and it was shown
previously that MDA-MB-231 cells responded to EGF gra-
dients in a chemotactic manner [20,21]. In general, linear
gradients of EGF were not effective in inducing directional
cell movement as compared to non-linear concentration
gradients.
Using the hybrid device, MDA-MB-231 cells were
observed for 5 hours in an EGF gradient (0–50 ng/ml)
with a withdrawal rate of 0.3 μl/min. EGF-containing
media was added to the right reservoir while the other res-
ervoirs contained media alone. Figure 3A shows that cells
were observed migrating toward higher concentrations of
EGF. Polarized extensions of lamellipodia toward higher
EGF concentrations were observed in the majority of cells
[see Additional File 5]. A Rayleigh test revealed that migra-
tion was directional toward high EGF concentration, and
the mean migration angle was 109.9° (p < 0.01; Figure
3B). In addition, cells in the steepest part of the gradient
(3–45 ng/ml) displayed the greatest directional migration
(Figure 3C), while cells elsewhere displayed random
movement (data not shown). These results (chemotactic
index, migration speed, directional orientation) were sim-
ilar to those obtained from previous microfluidic chemo-
taxis chambers [20,21].
Chemotaxis of human breast cancer cells in a concentration  gradient (0–50 ng/ml) of EGF Figure 3
Chemotaxis of human breast cancer cells in a concentration 
gradient (0–50 ng/ml) of EGF. (A) First and last images of 
cells in the gradient region after 5 hours. (B) Directional plot 
of migration angle in 3–45 ng/ml EGF gradients, grouped in 
10° intervals. (C) Cells inside the dotted lines (3–45 ng/ml 
EGF) were tracked and analyzed. The EGF gradient profile is 
visualized by FITC-dextran (10 kD) with a similar molecular 
weight to EGF. Scale bars are 20 μm.
Real-time optical live/dead assay for mouse NPCs using  microfluidics Figure 2
Real-time optical live/dead assay for mouse NPCs using 
microfluidics. (A) Schematic drawing of a fluidic network 
containing control and gradient region. (B-C) Mouse NPCs 
cultured in the control region of fluidic channel. Hydrogen 
peroxide (50 mM) was added into the right reservoir after 
preloading with propidium iodide (red). Cell death resulting 
from exposure to hydrogen peroxide was monitored by 
time-lapse microscopy. (D-E) Numbers of PI-positive cells 
increase towards the right side of the gradient chamber with 
longer exposure to hydrogen peroxide. Quantitative analysis 
of cell death in the control (F) and gradient region (G). Each 
bar shows the average for three independent experiments 
with standard errors of mean (*p < 0.05, **p < 0.01). Scale 
bars are 100 μm.BMC Biotechnology 2007, 7:60 http://www.biomedcentral.com/1472-6750/7/60
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Conclusion
This paper reports a hybrid microfluidic device inte-
grated with vacuum networks and its application in bio-
logical experiments. This device provides a simple yet
highly adaptable tool for incorporating the advantages
of microfluidics to basic biological assays without
changing established tissue culture protocols. One of the
main advantages of this chamber is that it can be directly
used on adherent cells cultured in a standard tissue cul-
ture plate. In addition, the hybrid microfluidic-vacuum
platform allows for higher throughput, generates stable
concentration gradients, and can be useful for studying
cellular behaviors of sensitive cells (mouse NPCs, neu-
rons). Using the advantages of this microfluidic plat-
form, we have developed real-time optical assays to
investigate cell proliferation and death in mouse NPCs,
and chemotaxis of MDA-MB-231 breast cancer cells
exposed to EGF gradients.
Methods
Fabrication and design of the microfluidic device
The microfluidic device was fabricated in PDMS using
previously published soft lithography procedures
[18,26-28]. Master molds were made by patterning 100
μm thick negative photoresist (Su-8 50, Microchem, MA)
on a Si Wafer. A negative replica of microchannels in
PDMS was fabricated by replica molding against the
photoresist patterned master mold. The gradient-gener-
ating microfluidic network was a simple design with 3
separate inlets (Figure 1A). The main channel was
divided into two regions: control and gradient area (Fig-
ure 2A). The control region had three separate 200 μm
wide microchannels separated by a 100 μm wide barrier.
Downstream of the control region, the three channels
combined into one channel that formed the gradient
region (800 μm wide) (Figure 2A).
Experimental setup
Sterility was maintained by performing most of the
experimental steps, including the assembly process, in a
laminar flow bench. Devices sterilized by UV light were
assembled on cell culture dishes. Small holes in the Petri
dish cover were used to provide vacuum and fluidic
channel access (tubing was threaded through these
holes), thus maintaining sterility of the device. To avoid
bubble formation in fluidic channels, devices were
treated with oxygen plasma to make fluidic channel sur-
faces more hydrophilic. Alternatively, devices were soni-
cated with deionized water or culture media for 5–10
min before applying to Petri dishes. Before placing the
device onto a Petri dish, half of the media was removed
by aspiration (approximately 1 ml remaining per 35 mm
dish) to facilitate vacuum application. When first assem-
bling the device, vacuum was generated with a 10 ml
syringe connected to a 3-way valve and polyethylene tub-
ing with 0.38 mm inner diameter. After placing the
device on the microscope or in the incubator, house vac-
uum was used to maintain continuous vacuum. To mon-
itor cells in real-time, this experimental setup was
maintained over 1 day. The Petri dish was placed on a
time-lapse microsope with a 37°C, 5% CO2 chamber.
Neural precursor cell (NPC) culture
Mice
Wild-type (WT) CD1 mice were used for these studies. To
retrieve embryos at certain ages, pregnancies were timed.
Successful impregnation occurs at the midpoint of the
light-dark cycle (approximately 12 midnight) and is vis-
ually detectable the next day by a "vaginal plug", a hard-
ened waxy concretion in the vaginal vault. Noon of the
plug date is therefore designated as embryonic day 0.5.
All developmental ages were confirmed by embryo
crown-rump measurements. All animal studies were
done in accordance with Institutional Animal Care and
Use Committee guidelines.
NPC culture
Telencephalic NPC cultures were prepared from embryos
harvested on gestational day 12.5, as described [29].
Briefly, telencephalic vesicles were isolated and placed
for 20 min at 37°C in Hanks' Balanced Salt Solution
(HBSS, Invitrogen, CA) containing 0.05% trypsin, 0.02%
EDTA (Invitrogen, CA), and 0.2% bovine serum albu-
min (BSA) (ICN Biomedicals, Aurora, Ohio). Trypsiniza-
tion was stopped by adding an equal volume of 1 mg/ml
soybean trypsin inhibitor (Invitrogen, CA) in PBS. Tis-
sues were then mechanically dissociated using several
rounds of trituration using a fire-polished Pasteur
pipette. Cells were washed once with HBSS containing
0.2% BSA and then resuspended in media with 10 ng/ml
fibroblast growth factor 2 (FGF2), 20 ng/ml epidermal
growth factor (EGF), and 2 μg/ml heparin. Cells were
grown as neurospheres in 6-well non-tissue culture
treated plates at the density of 100,000 cells/well at 37°C
in a humidified 5% CO2/95% air atmosphere for 3 days.
Neurospheres were then dissociated with the NeuroCult
Chemical Dissociation Kit (Stem Cell Technologies).
Dissociated cells were plated on poly-d-lysine and lam-
inin coated 6-well tissue culture treated plates (Corning,
NY) at 600,000 cells/well in media with 10 ng/ml FGF2,
20 ng/ml EGF, and 2 μg/ml heparin for 24 hours before
applying the microfluidic device.
Real-time live/dead cell assay
Plated mouse NPCs on Petri dishes were prepared. A
microfluidic device was placed onto the Petri dish as
described above. Media spiked with PI (2 μg/ml) was
applied into the three reservoirs for 30 min prior to
exposing with hydrogen peroxide. This provided the
baseline for fluorescence intensity of dead cells presentBMC Biotechnology 2007, 7:60 http://www.biomedcentral.com/1472-6750/7/60
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at the start of the experiment. After initiating time-lapse
fluorescence monitoring, media containing 50 mM
hydrogen peroxide was placed into the right reservoir.
Cancer cell culture
The human metastatic breast cancer cells (MDA-MB-
231) were cultured in Leibovitz's L15 media with L-
glutamine (Invitrogen, CA) and 10% fetal bovine serum
(FBS, Gibco, CA). Cells were plated at a density of
250,000 cells/ml and incubated overnight at 37°C in 60
mm Petri dishes. During the starvation process, serum-
free L15 media was added to the cells and then incubated
at 37°C for 90 minutes. A microfluidic device was placed
onto the Petri dish and attached via vacuum. L15 media
with 10% FBS was then added to each of the 3 inlet chan-
nels. 50 ng/ml recombinant human EGF (BD Bio-
sciences, MA) mixed with L15 media containing 10%
FBS was placed in the right inlet channel. Cell migration
was observed for 5 hours using time-lapse microscopy.
Time-lapse microscopy and migration analysis
The microfluidic device was sealed to adherent cells cul-
tured in a well plate and placed in an inverted micro-
scope (Nikon TE300, NY) equipped with an
environmental chamber (37°C and 5% CO2). Phase
contrast and fluorescence images of cells were taken
every 1 min with a digital CCD camera (CoolSNAP cf,
Roper Scientific, AZ) controlled with Metamorph
(Molecular Devices, PA). Cell tracking and image analy-
sis were performed using Metamorph. Statistical analysis
of cell migration speed and angles were performed with
Oriana (Kovach Computing Services, UK) using a proce-
dure described previously [20,21].
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